A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB –IIIA resectable NSCLC
ConclusionsFractional decrease in FDG SULmax from baseline to post-cycle 1 imaging was significantly different between anatomic responders and non-responders, while percentage changes in FLT SULmax were not significantly different between these groups over the same period of time.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Docetaxel | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | PET Scan | Radiology | Study | Taxotere